![]() |
![]() | ![]() |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
Was wondering if anyone has invested in this company or has been following it. IMM was drawn to my attention when I attended a live talk stock forum, with a small cap stock investor on 1/29/97. He stated that he had just invested in this company's stock. After I had checked out IMM, I felt this would be a good company to start a thread on as they are involved in research with new monoclonal antibodies as potential HIV therapy. Their tests have shown good results on both HIV and AIDS infected monkeys. They also will be working with scientists at the New England Primate Center and Harvard University. Your comments would be welcome. Al | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |